282 related articles for article (PubMed ID: 9337377)
21. Malignant potential and cytogenetic characteristics of occult disseminated tumor cells in esophageal cancer.
Hosch S; Kraus J; Scheunemann P; Izbicki JR; Schneider C; Schumacher U; Witter K; Speicher MR; Pantel K
Cancer Res; 2000 Dec; 60(24):6836-40. PubMed ID: 11156375
[TBL] [Abstract][Full Text] [Related]
22. Significance of immunohistochemical nodal micrometastasis as a prognostic indicator in potentially curable oesophageal carcinoma.
Komukai S; Nishimaki T; Suzuki T; Kanda T; Kuwabara S; Hatakeyama K
Br J Surg; 2002 Feb; 89(2):213-9. PubMed ID: 11856137
[TBL] [Abstract][Full Text] [Related]
23. Detection of disseminated lung cancer cells in lymph nodes: impact on staging and prognosis.
Passlick B; Izbicki JR; Kubuschok B; Thetter O; Pantel K
Ann Thorac Surg; 1996 Jan; 61(1):177-82; discussion 183. PubMed ID: 8561549
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of immunohistochemically detected lymph node micrometastases in pT0N0 esophageal squamous cell carcinoma.
Chao YK; Yeh CJ; Chuang WY; Fan KH; Hsieh MJ; Chu Y; Cheng AJ; Liu HP
J Surg Oncol; 2009 Dec; 100(7):559-62. PubMed ID: 19653242
[TBL] [Abstract][Full Text] [Related]
25. Appraisal of a revised lymph node classification system for esophageal squamous cell cancer.
Dhar DK; Hattori S; Tonomoto Y; Shimoda T; Kato H; Tachibana M; Matsuura K; Mitsumoto Y; Little AG; Nagasue N
Ann Thorac Surg; 2007 Apr; 83(4):1265-72. PubMed ID: 17383324
[TBL] [Abstract][Full Text] [Related]
26. Prediction model of lymph node metastasis in superficial esophageal adenocarcinoma and squamous cell cancer including D2-40 immunostaining.
Gockel I; Domeyer M; Sgourakis GG; Schimanski CC; Moehler M; Kirkpatrick CJ; Lang H; Junginger T; Hansen T
J Surg Oncol; 2009 Sep; 100(3):191-8. PubMed ID: 19548259
[TBL] [Abstract][Full Text] [Related]
27. The range of tumor extension should have precedence over the location of the deepest tumor center in determining the regional lymph node grouping for widely extending esophageal carcinomas.
Ueda Y; Shiozaki A; Itoi H; Okamoto K; Fujiwara H; Ichikawa D; Kikuchi S; Fuji N; Itoh T; Ochiai T; Yamagishi H
Jpn J Clin Oncol; 2006 Dec; 36(12):775-82. PubMed ID: 17043058
[TBL] [Abstract][Full Text] [Related]
28. [Distribution of lymph nodes and lymph node metastases in esophageal carcinoma].
Fraunberger L; Kraus B; Dworak O
Zentralbl Chir; 1996; 121(2):102-5. PubMed ID: 8868603
[TBL] [Abstract][Full Text] [Related]
29. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
Steven K; Poulsen AL
J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
[TBL] [Abstract][Full Text] [Related]
30. Is it time for a new TNM classification in esophageal carcinoma?
Bogoevski D; Onken F; Koenig A; Kaifi JT; Schurr P; Sauter G; Izbicki JR; Yekebas EF
Ann Surg; 2008 Apr; 247(4):633-41. PubMed ID: 18362626
[TBL] [Abstract][Full Text] [Related]
31. Clinical implications of lymph node micrometastasis in patients with histologically node-negative (pN0) esophageal carcinoma.
Nakamura T; Ide H; Eguchi R; Hayashi K; Ota M; Takasaki K
J Surg Oncol; 2002 Apr; 79(4):224-9. PubMed ID: 11920779
[TBL] [Abstract][Full Text] [Related]
32. Lymphatic spread and microinvolvement in adenocarcinoma of the esophago-gastric junction.
Schurr PG; Yekebas EF; Kaifi JT; Lasch S; Strate T; Kutup A; Cataldegirmen G; Bubenheim M; Pantel K; Izbicki JR
J Surg Oncol; 2006 Sep; 94(4):307-15. PubMed ID: 16917878
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of lymph node metastases in early esophageal carcinoma and treatment regimens].
Li L; Liu SY; Zhu KS; Chen JQ; Ying MG
Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):226-9. PubMed ID: 19615267
[TBL] [Abstract][Full Text] [Related]
34. Prognostic variables in thoracic esophageal squamous cell carcinoma.
Lin CS; Chang SC; Wei YH; Chou TY; Wu YC; Lin HC; Wang LS; Hsu WH
Ann Thorac Surg; 2009 Apr; 87(4):1056-65. PubMed ID: 19324127
[TBL] [Abstract][Full Text] [Related]
35. The prognostic impact of isolated tumor cells in lymph nodes of T2N0 gastric cancer: comparison of American and Japanese gastric cancer patients.
Fukagawa T; Sasako M; Shimoda T; Sano T; Katai H; Saka M; Mann GB; Karpeh M; Coit DG; Brennan MF
Ann Surg Oncol; 2009 Mar; 16(3):609-13. PubMed ID: 19137375
[TBL] [Abstract][Full Text] [Related]
36. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
37. [Lymphatic metastasis intensity of and lymphadenectomy for thoracic esophageal squamous cell carcinoma].
Lu ZM; Zhang H; Wang MH; Cui DH; Yang YQ; Huang HZ
Ai Zheng; 2006 May; 25(5):604-8. PubMed ID: 16687083
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of detecting mucin 1 mRNA in diagnosing occult lymph node micrometastasis in esophageal cancer patients.
Liu XY; Chen G; Wang Z; Liu FY
Ai Zheng; 2007 Feb; 26(2):194-9. PubMed ID: 17298752
[TBL] [Abstract][Full Text] [Related]
39. Prediction of lymph node status in patients with superficial esophageal carcinoma: analysis of 160 surgically resected cancers.
Shimada H; Nabeya Y; Matsubara H; Okazumi S; Shiratori T; Shimizu T; Aoki T; Shuto K; Akutsu Y; Ochiai T
Am J Surg; 2006 Feb; 191(2):250-4. PubMed ID: 16442955
[TBL] [Abstract][Full Text] [Related]
40. Prognostic influence of immunohistochemically detected lymph node micrometastasis and histological subtype in pN0 oesophageal cancer.
Zingg U; Montani M; Busch M; Metzger U; Went P; Oertli D
Eur J Surg Oncol; 2009 Jun; 35(6):593-9. PubMed ID: 19121916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]